BG Stock Analysis: Bunge Global | NYSE
Farm Products | NYSE, USA | Market Cap: 22.186m USD | 12M Return: 50.1% | CH1300646267 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 144M
EPS Trend: -91.8%
Qual. Beats: 0
Rev. Trend: 59.7%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bunge Global SA is a global agribusiness and food company headquartered in Chesterfield, Missouri, with operations spanning four segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. The company purchases, stores, transports, processes, distributes, refines, markets, and sells agricultural commodities and related products, including soybeans, softseeds, corn, wheat, barley, cotton, pulses, and sugar, serving the food, animal feed, and biofuel industries.
Founded in 1818, Bunge is one of the worlds largest oilseed processors and a member of the ABCD group of major global agricultural commodity traders (alongside ADM, Cargill, and Louis Dreyfus). The company also produces biodiesel and fertilizer, and operates milling operations for wheat and sugar, reflecting the vertically integrated nature typical of large-scale agricultural processors. Bunge is listed on the NYSE under the ticker BG and falls within the Consumer Staples sector, specifically the Agricultural Products & Services sub-industry.
- Soybean crush margins drive core oilseed segment earnings
- Viterra acquisition expands global grain origination scale
- Biodiesel demand lifts edible oil processing margins
| Net Income: 1.01b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 0.20 > 1.0 |
| NWC/Revenue: 10.33% < 20% (prev 21.75%; Δ -11.42% < -1%) |
| CFO/TA 0.02 > 3% & CFO 1.07b > Net Income 1.01b |
| Net Debt (17.8b) to EBITDA (2.51b): 7.10 < 3 |
| Current Ratio: 1.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (196.0m) vs 12m ago 44.54% < -2% |
| Gross Margin: 4.94% > 18% (prev 5.77%; Δ -0.83% > 0.5%) |
| Asset Turnover: 235.6% > 50% (prev 163.3%; Δ 72.36% > 0%) |
| Interest Coverage Ratio: 1.83 > 6 (EBIT TTM 2.04b / Interest Expense TTM 1.12b) |
| A: 0.20 (Total Current Assets 26.2b - Total Current Liabilities 16.7b) / Total Assets 46.8b |
| B: 0.29 (Retained Earnings 13.3b / Total Assets 46.8b) |
| C: 0.05 (EBIT TTM 2.04b / Avg Total Assets 39.0b) |
| D: 0.54 (Book Value of Equity 16.0b / Total Liabilities 29.4b) |
| Altman-Z'' = 3.18 = A |
| DSRI: 0.78 (Receivables 3.93b/2.79b, Revenue 91.8b/50.9b) |
| GMI: 1.17 (GM 5.77% / 4.94%) |
| AQI: 1.60 (AQ_t 0.15 / AQ_t-1 0.09) |
| SGI: 1.81 (Revenue 91.8b / 50.9b) |
| TATA: -0.00 (NI 1.01b - CFO 1.07b) / TA 46.8b) |
| Beneish M = -2.12 (Cap -4..+1) = BB |
As of September 05, 2026, the stock is trading at USD 118.71 with a total of 1,174,922 shares traded. Over the past week, the price has changed by +2.80%, over one month by +11.93%, over three months by -7.70% and over the past year by +50.07%.
Current recommended Stop Loss: 108.10 (which is 8.9% or 2.5 ATR below the current price).
Bunge Global has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy BG.
- StrongBuy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 141.2 | 19% |
P/E Trailing = 24.0583
P/E Forward = 14.5349
P/S = 0.2416
P/B = 1.3436
P/EG = 1.7053
Revenue TTM = 91.8b USD
EBIT TTM = 2.04b USD
EBITDA TTM = 2.51b USD
Long Term Debt = 9.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.29b USD (from shortTermDebt, last quarter)
Debt = 18.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.60b
Net Debt = 17.8b USD (calculated: Debt 18.4b - CCE 593.0m)
Enterprise Value = 40.0b USD (22.2b + Debt 18.4b - CCE 593.0m)
Interest Coverage Ratio = 1.83 (Ebit TTM 2.04b / Interest Expense TTM 1.12b)
EV/FCF = -56.26x (Enterprise Value 40.0b / FCF TTM -711.0m)
FCF Yield = -1.78% (FCF TTM -711.0m / Enterprise Value 40.0b)
FCF Margin = -0.77% (FCF TTM -711.0m / Revenue TTM 91.8b)
Net Margin = 1.10% (Net Income TTM 1.01b / Revenue TTM 91.8b)
Gross Margin = 4.94% ((Revenue TTM 91.8b - Cost of Revenue TTM 87.3b) / Revenue TTM)
Gross Margin QoQ = 6.99% (prev 3.50%)
Tobins Q-Ratio = 0.86 (Enterprise Value 40.0b / Total Assets 46.8b)
Interest Expense / Debt = 6.07% (Interest Expense 1.12b / Debt 18.4b)
Taxrate = 34.77% (306.0m / 880.0m)
NOPAT = 1.33b (EBIT 2.04b * (1 - 34.77%))
Current Ratio = 1.57 (Total Current Assets 26.2b / Total Current Liabilities 16.7b)
Debt / Equity = 1.15 (Debt 18.4b / totalStockholderEquity, last quarter 16.0b)
Debt / EBITDA = 7.10 (Net Debt 17.8b / EBITDA 2.51b)
Debt / FCF = -25.06 (negative FCF - burning cash) (Net Debt 17.8b / FCF TTM -711.0m)
Total Stockholder Equity = 15.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.59% (Net Income 1.01b / Total Assets 46.8b)
RoE = 6.35% (Net Income TTM 1.01b / Total Stockholder Equity 15.9b)
RoCE = 8.06% (EBIT 2.04b / Capital Employed (Equity 15.9b + L.T.Debt 9.43b))
RoIC = 3.73% (NOPAT 1.33b / Invested Capital 35.7b)
WACC = 5.07% (E(22.2b)/V(40.6b) * Re(6.0%) + D(18.4b)/V(40.6b) * Rd(6.07%) * (1-Tc(0.35)))
Discount Rate = 6.0% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.79 | Cagr: 14.33%
[DCF] Fair Price = unknown (Cash Flow -711.0m)
EPS Correlation: -91.80 | EPS CAGR: -22.73% | SUE: -0.08 | # QB: 0
Revenue Correlation: 59.66 | Revenue CAGR: 12.93% | SUE: 1.52 | # QB: 1
EPS current Quarter (2026-09-30): EPS=2.47 | Chg30d=-4.47% | Revisions=-44% | Analysts=7
EPS current Year (2026-12-31): EPS=9.64 | Chg30d=+1.99% | Revisions=+67% | GrowthEPS=+27.3% | GrowthRev=+30.5%
EPS next Year (2027-12-31): EPS=11.34 | Chg30d=+1.69% | Revisions=+22% | GrowthEPS=+17.7% | GrowthRev=+2.8%
[Analyst] Revisions Ratio: +19% (up=11, down=7)